Flagship Pioneering
Undisclosed; no standardized first-check range is published in the reviewed sources. · idea, pre-seed, seed, growth · Global
Institutional venture-creation platform inventing and building companies in human health, sustainability and AI through a systematic scientific process.
Tier 3biostudio
Visit / pitchOfficial siteOpen in the live directory
Key facts
| Fund size | $2.6B Fund VIII plus $1B side funds (2024) |
| Stage | idea, pre-seed, seed, growth |
| Typical first check | Undisclosed; no standardized first-check range is published in the reviewed sources. |
| Sectors | biotechnology, healthcare, agriculture, sustainability, ai |
| Geography | Global |
| Status | open |
Always confirm on the official page before applying — dates and terms change.
Background
Institutional venture-creation platform inventing and building companies in human health, sustainability and AI through a systematic scientific process. The reviewed sources distinguish disclosed facts from comparable economics that remain private.
How the application really works
No dedicated public pitch route was confirmed. Use the official team page to identify a relevant investor and seek a trusted introduction without inferring private contact details.
Tips
- Lead with explicit fit for idea, pre-seed, seed, growth and Global.
- Use the official portfolio and team pages to choose the most relevant route.
Watch out for
- Quoting an uncited check, ownership target, or decision time as firm policy.
- Sending an undifferentiated pitch outside the published thesis.
Track record
- Flagship founded Moderna and more than 100 scientific ventures; its current company page includes Generate, Inari, Tessera, Quotient and Lila Sciences.
No comparable acceptance or investment-rate statistic is published.
Investment thesis
Originate breakthrough scientific hypotheses, validate them internally and build first-in-category platform companies.
How to reach them
- Target a relevant current investor through a trusted introduction.
Notable portfolio
ModernaGenerate:BiomedicinesInariTesseraLila Sciences
Frequently asked questions
- What stage does the firm invest at?
- idea, pre-seed, seed, growth
- What is the latest disclosed fund or capital base?
- $2.6B Fund VIII plus $1B side funds (2024).
- What check size does it write?
- Undisclosed; no standardized first-check range is published in the reviewed sources.
- Where does it invest?
- Global
- How can a founder approach the firm?
- No dedicated public pitch route was confirmed. Use the official team page to identify a relevant investor and seek a trusted introduction without inferring private contact details.
- What remains undisclosed?
- Comparable check range, ownership target, reserves allocation, decision speed and a universal board policy remain undisclosed unless explicitly stated above.
Related venture funds
Sources
- www.flagshippioneering.com/companies — Official portfolio and outcome evidence. (checked 2026-08-10)
- www.flagshippioneering.com — Current official positioning and activity. (checked 2026-08-10)
- www.flagshippioneering.com/about — Official investment strategy, stage, or founder criteria. (checked 2026-08-10)
- www.flagshippioneering.com/people — Current official investment team. (checked 2026-08-10)
- www.flagshippioneering.com/news/press-release/flagship-pioneering-raises-3-6-billion-to-fuel-breakthrough-innovations-that-transform-human-health-and-sustainability — Latest comparable public capital evidence. (checked 2026-08-10)